combination drug: buprenorphine / naloxone
- Suboxone® (Reckitt Benckiser) FDA approved indications: treatment of Opioid Dependence 10.8.2002
- FDA information:
| Dose: | 2.0 mg. buprenorphine/0.5 mg. naloxone | 8.0/mg. buprenorphine/2.0 mg. naloxone | ||
| Color: | orange | orange | ||
| Shape: | hexagonal | hexagonal | ||
| Type: | tablet | tablet | ||
| Imprint: | sword logo | "N2" | sword logo | "N8" |
